Polycystic ovary syndrome awareness among patients in a tertiary level teaching hospital: a questionnaire based observational study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250856Keywords:
Endocrine disorders, Health education, Polycystic ovary syndrome, Reproductive healthAbstract
Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age. Despite its widespread occurrence, awareness remains inconsistent. This study aims to evaluate the awareness, knowledge, and perceptions of PCOS among participants, focusing on risk factors, symptoms, diagnostic modalities, treatment approaches, and sources of information.
Methods: An observational study was conducted among women from diverse educational and occupational backgrounds. Data was collected through structured questionnaires assessing demographic details, awareness levels, knowledge of risk factors and symptoms, diagnostic approaches, treatment-seeking behaviour, and sources of information. Responses were analysed to identify trends, misconceptions, and gaps in knowledge.
Results: The study showed that 40.6% of participants were aware of PCOS, a significant portion (39.6%) reported only partial awareness. The most commonly identified symptom was irregular periods (76.8%). A majority of participants (46.4%) were unsure about seeking medical treatment, reflecting hesitancy and misinformation. Management strategies such as lifestyle changes (32.9%) and medications (29.9%) were known to participants, but awareness of surgical options was low (4.3%). Notably, 30.4% of respondents relied on family and friends as their primary source of information, raising concerns about the accuracy of their knowledge.
Conclusions: The findings highlight significant gaps in PCOS awareness, diagnosis, and management. Healthcare professionals play a crucial role in disseminating accurate information. Targeted educational interventions, enhanced healthcare communication, and community-based awareness programs are necessary to bridge knowledge gaps and promote early diagnosis and effective management of PCOS.
Metrics
References
Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439-2473. DOI: https://doi.org/10.1007/s10815-022-02625-7
Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560-74. DOI: https://doi.org/10.1093/humupd/dmv025
Wang J, Yin T, Liu S. Dysregulation of immune response in PCOS organ system. Front Immunol. 2023;14:1169232. DOI: https://doi.org/10.3389/fimmu.2023.1169232
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43-G64.
Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018;110(5):794-809. DOI: https://doi.org/10.1016/j.fertnstert.2018.08.021
Fernandez RC, Moore VM, Rumbold AR, Whitrow MJ, Avery JC, Davies MJ. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Hum Reprod. 2021;36(8):2275-2284. DOI: https://doi.org/10.1093/humrep/deab101
Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract ResClin Obstet Gynaecol. 2004;18:671-83. DOI: https://doi.org/10.1016/j.bpobgyn.2004.05.001
Talbott EO, Zborowskii JV, Boudraux MY. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence. Minerva Ginecol. 2004;56(1):27-39. DOI: https://doi.org/10.1016/j.ics.2004.02.007
Kaundal A, Renjhen P, Kumari R. Awareness of lifestyle modifications in the management of polycystic ovarian syndrome: a hospital-based descriptive cross-sectional study. Cureus. 2023;15(3):e36889. DOI: https://doi.org/10.7759/cureus.36889
Sydora BC, Wilke MS, McPherson M, Chambers S, Ghosh M, Vine DF. Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care. BMC Womens Health. 2023;23(1):569. DOI: https://doi.org/10.1186/s12905-023-02732-2
Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685-97. DOI: https://doi.org/10.1016/S0140-6736(07)61345-2
Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148-59. DOI: https://doi.org/10.1111/j.1471-0528.2006.00990.x
Bordewijk EM, Ng KYB, Rakic L, Mol BWJ, Brown J, Crawford TJ, van Wely M. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;2(2):CD001122. DOI: https://doi.org/10.1002/14651858.CD001122.pub5
Jena SK, Mishra L, Naik SS, Khan S. Awareness and opinion about polycystic ovarian syndrome (PCOS) among young women: a developing country perspective. Int J Adolesc Med Health. 2020;33(3):123-126. DOI: https://doi.org/10.1515/ijamh-2018-0166
Jabeen A, Yamini V, Rahman Amberina A, Dinesh Eshwar M, Vadakedath S, Begum GS, et al. Polycystic ovarian syndrome: prevalence, predisposing factors, and awareness among adolescent and young girls of south India. Cureus. 2022;14(8):e27943. DOI: https://doi.org/10.7759/cureus.27943